Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |